Nuclear PTEN safeguards pre-mRNA splicing to link Golgi apparatus for its tumor suppressive role

Shao-Ming Shen1, Yan Ji2, Cheng Zhang3

  • 1Department of Pathophysiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, 200025, China. smshen01@sibs.ac.cn.

Nature Communications
|June 21, 2018
PubMed

Insights

Tumor suppressor PTEN deletion alters pre-mRNA splicing, impacting cancer patient outcomes. PTEN interacts with the spliceosome, and its depletion sensitizes cancer cells to secretion inhibitors, offering new therapeutic strategies for PTEN-deficient cancers.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Dysregulation of pre-mRNA alternative splicing (AS) is linked to cancer development.
  • The interplay between AS and tumor suppressors like PTEN is not well understood.

Purpose of the Study:

  • To investigate the role of PTEN in regulating alternative splicing.
  • To identify PTEN-regulated AS events and their association with cancer patient prognosis.
  • To explore the therapeutic potential of targeting pathways affected by PTEN loss.

Main Methods:

  • RNA sequencing to identify PTEN-regulated AS events in 293T cells.
  • Analysis of PTEN-spliceosome interactions.
  • Investigating the functional impact of a novel GOLGA2 exon on tumorigenesis.
  • Assessing sensitivity to secretion inhibitors in PTEN-depleted cancer cells.

Main Results:

  • PTEN deletion alters pre-mRNA splicing independently of its phosphatase activity.
  • 262 PTEN-regulated AS events were identified, correlating with worse cancer patient outcomes.
  • Nuclear PTEN interacts with the spliceosome, influencing its assembly and splicing.
  • A novel GOLGA2 exon (2b) exclusion promotes tumorigenesis via Golgi extension and secretion.
  • PTEN depletion sensitizes cancer cells to secretion inhibitors (brefeldin A, golgicide A).

Conclusions:

  • PTEN plays a crucial role in regulating alternative splicing through spliceosome interaction.
  • PTEN-regulated AS events serve as potential biomarkers for cancer prognosis.
  • Targeting Golgi secretion pathways, potentially combined with PI3K/Akt inhibitors, may be effective for PTEN-deficient cancers.

Related Concept Videos

Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

7.0K
Golgi Apparatus01:49

Golgi Apparatus

As they leave the Endoplasmic Reticulum (ER), properly folded and assembled proteins are selectively packaged into vesicles. These vesicles are transported by microtubule-based motor proteins and fuse together to form vesicular tubular clusters, subsequently arriving at the Golgi apparatus, a eukaryotic endomembrane organelle that often has a distinctive ribbon-like appearance.
103.0K
Golgi Apparatus01:09

Golgi Apparatus

Properly folded and assembled proteins are selectively packaged into vesicles that exit the ER. Motor proteins transport these vesicles to the Golgi apparatus for adding modifications that make these proteins functional at their destination.
The Golgi apparatus is a eukaryotic organelle that has a distinctive ribbon-like appearance. It is a primary sorting and dispatch station for cargo arriving from the ER. Newly arriving vesicles enter the cis face of the Golgi, closest to the ER, and are...
21.9K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.2K
pre-mRNA Processing02:01

pre-mRNA Processing

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K